High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration

被引:59
作者
Paulsson, K [1 ]
Heidenblad, M
Strömbeck, B
Staaf, J
Jönsson, G
Fioretos, T
Johansson, B
机构
[1] Univ Lund Hosp, Dept Clin Genet, SE-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[3] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden
关键词
myeloid leukemia; myelodysplastic syndromes; trisomy; 8; chromosome aberration; array CGH;
D O I
10.1038/sj.leu.2404145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although trisomy 8 as the sole chromosome aberration is the most common numerical abnormality in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), little is known about its pathogenetic effects. Considering that +8 is a frequent secondary change in AML/MDS, cryptic - possibly primary - genetic aberrations may occur in cases with trisomy 8 as the apparently single anomaly. However, no such hidden anomalies have been reported. We performed a high-resolution genome-wide array-based comparative genome hybridization (array CGH) analysis of 10 AML/MDS cases with isolated +8, utilizing a 32K bacterial artificial chromosome array set, providing 498% coverage of the genome with a resolution of 100 kb. Array CGH revealed intrachromosomal imbalances, not corresponding to known genomic copy number polymorphisms, in 4/10 cases, comprising nine duplications and hemizygous deletions ranging in size from 0.5 to 2.2 Mb. A 1.8Mb deletion at 7p14.1, which had occurred prior to the +8, was identified in MDS transforming to AML. Furthermore, a deletion including ETV6 was present in one case. The remaining seven imbalances involved more than 40 genes. The present results show that cryptic genetic abnormalities are frequent in trisomy 8-positive AML/MDS cases and that +8 as the sole cytogenetic aberration is not always the primary genetic event.
引用
收藏
页码:840 / 846
页数:7
相关论文
共 33 条
[1]   Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents [J].
Albin, M ;
Björk, J ;
Welinder, H ;
Tinnerberg, H ;
Mauritzson, N ;
Johansson, B ;
Billström, R ;
Strömberg, U ;
Mikoczy, Z ;
Ahgren, T ;
Nilsson, PG ;
Mitelman, F ;
Hagmar, L .
SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2000, 26 (06) :482-491
[2]  
Andreasson P, 1997, GENE CHROMOSOME CANC, V19, P77, DOI 10.1002/(SICI)1098-2264(199706)19:2<77::AID-GCC2>3.0.CO
[3]  
2-X
[4]   CGH-Plotter: MATLAB toolbox for CGH-data analysis [J].
Autio, R ;
Hautaniemi, S ;
Kauraniemi, P ;
Yli-Harja, O ;
Astola, J ;
Wolf, M ;
Kallioniemi, A .
BIOINFORMATICS, 2003, 19 (13) :1714-1715
[5]   Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme [J].
Cowell, JK ;
Matsui, SI ;
Wang, YD ;
LaDuca, J ;
Conroy, J ;
McQuaid, D ;
Nowak, NJ .
CANCER GENETICS AND CYTOGENETICS, 2004, 151 (01) :36-51
[6]  
Cox Maria Christina, 2003, Hematol J, V4, P263, DOI 10.1038/sj.thj.6200262
[7]   Rapid array-based genomic characterization of a subtle structural abnormality: A patient with psychosis and der(18)t(5;18)(p14.1;p11.23) [J].
Drazinic, CM ;
Ercan-Sencicek, AG ;
Gault, LM ;
Hisama, FM ;
Qumsiyeh, MB ;
Nowak, NJ ;
Cubells, JF ;
State, MW .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 134A (03) :282-289
[8]   The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia:: implications for diagnosis, classification, and management [J].
Gotlib, J ;
Cools, J ;
Malone, JM ;
Schrier, SL ;
Gilliland, DG ;
Coutré, SE .
BLOOD, 2004, 103 (08) :2879-2891
[9]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[10]   High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia [J].
Harada, H ;
Harada, Y ;
Niimi, H ;
Kyo, T ;
Kimura, A ;
Inaba, T .
BLOOD, 2004, 103 (06) :2316-2324